Clinical Trial Update: Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy before autologous stem cell transplantation with or without rituximab in relapsed/refractory aggressive non-Hodgkin lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2014-10-21